Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma

Toshihiko Doi, Sarina A. Piha-Paul, Shadia I. Jalal, Sanatan Saraf, Jared Lunceford, Minori Koshiji, Jaafar Bennouna

Research output: Contribution to journalArticlepeer-review

111 Scopus citations

Fingerprint Dive into the research topics of 'Safety and antitumor activity of the anti-programmed death-1 antibody pembrolizumab in patients with advanced esophageal carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences